HomeNZM • FRA
add
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
Nakaraang pagsara
€54.00
Sakop ng araw
€53.00 - €53.00
Sakop ng taon
€49.40 - €66.00
Market cap
166.09B DKK
Average na Volume
47.00
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.60B | 1.63% |
Gastos sa pagpapatakbo | 1.42B | — |
Net na kita | 698.00M | — |
Net profit margin | 15.16 | — |
Kita sa bawat share | 3.06 | — |
EBITDA | 1.21B | — |
Aktuwal na % ng binabayarang buwis | 24.70% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.12B | — |
Kabuuang asset | 28.39B | — |
Kabuuang sagutin | 14.04B | — |
Kabuuang equity | 14.35B | — |
Natitirang share | 464.62M | — |
Presyo para makapag-book | 1.07 | — |
Return on assets | 9.38% | — |
Return on capital | 12.09% | — |
Cash Flow
Net change in cash
| (DKK) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 698.00M | — |
Cash mula sa mga operasyon | 1.12B | — |
Cash mula sa pag-invest | -603.00M | — |
Cash mula sa financing | -555.00M | — |
Net change in cash | -59.00M | — |
Malayang cash flow | 718.50M | — |
Tungkol
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
CEO
Itinatag
2000
Website
Mga Empleyado
10,582
